RareStone Group news

The narcolepsy drug Wakix can now be prescribed to patients in China with urgent unmet medical needs
 
BOSTON, Mass., and Boao, Hainan, China, May 07, 2021 – Citrine Medicine, a China-based rare disease therapeutics company, today announced that the narcolepsy therapy Wakix^® (pitolisant) has been approved by the Health Commission and Medical Products Administration of Hainan Province for its Named Patient Program (NPP). Through this pr